Clinical Trial Update: TTVR Early Feasibility Study [NA]

View source ↗

Summary

This document provides an update on Medtronic's transcatheter tricuspid valve replacement (TTVR) early feasibility study. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tricuspid Regurgitation

Drugs mentioned

• Transcatheter Tricuspid Valve Replacement (TTVR)

Snippet

Sponsor: Medtronic Cardiovascular | Conditions: Tricuspid Regurgitation | NA | Status: RECRUITING